On January 15, 2021, XPhyto Therapeutics Corp. (CNSX:XPHY) closed the transaction. In connection with the Offering, the Company paid a cash fee of CAD 228,000 and issued 120,000 finder’s warrants to Canaccord Genuity Corp. Each finder's warrant entitles the holder to purchase one common share at an exercise price of CAD 1.90 per share until January 15, 2023.